Thrombosis Canada/LinkedIn
Dec 6, 2025, 06:25
Dr. Jeff Weitz Unpacks the Latest ROXI-VTE Trials
Thrombosis Canada shared a new post on LinkedIn:
“New episode!
We sat down with Dr. Jeff Weitz to unpack the latest ROXI-VTE trials and what the data could mean for the future of thrombosis prevention.
If you manage patients at risk of VTE, don’t miss this conversation—full of clinical insights, context, and what’s coming next.
Episode goes live across all platforms within 24 hours, but if you can wait, listen to it here.
Title: ROXI-VTE Trials Explained: Dr. Jeff Weitz on Next-Generation Thrombosis Prevention”
Get the latest with Hemostasis Today.
-
Dec 8, 2025, 11:23Jorge Di Paola and Diane Krause Take Their Awards at ASH25
-
Dec 8, 2025, 11:08Andreas Tiede: This Will Change Hematology Forever
-
Dec 8, 2025, 09:39Asfand Yar Cheema Honored with Abstract Achievement Awards at ASH25
-
Dec 8, 2025, 09:27Ana Rita Rodrigues on the Impact of Post-Stroke Dysphagia
-
Dec 8, 2025, 09:19Sanam Loghavi and Shannon McWeeney at Joint Session on AI nad Hematology at ASH25
-
Dec 7, 2025, 18:43ASH25 Day 2: Don’t Miss The Highlights
-
Dec 7, 2025, 18:05Heghine Khachatryan Highlights a Patient-Friendly Breakthrough: Finger-Prick Micro-Sampling for Platelet Function
-
Dec 7, 2025, 17:01Abdul Mannan: How Do You Manage a Major Surgery When Blood Transfusion is Impossible?
-
Dec 7, 2025, 16:51Ahmed Bahi on Lina Merghani’s Critique of Early Withdrawal of Aspirin after PCI